Cargando…
Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?
BACKGROUND: We aimed to investigate whether visceral adiposity could modify the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes. METHODS: This cross-sectional study examines the interaction of visceral adiposity with increased blood pressure on arteria...
Autores principales: | Bouchi, Ryotaro, Ohara, Norihiko, Asakawa, Masahiro, Nakano, Yujiro, Takeuchi, Takato, Murakami, Masanori, Sasahara, Yuriko, Numasawa, Mitsuyuki, Minami, Isao, Izumiyama, Hajime, Hashimoto, Koshi, Yoshimoto, Takanobu, Ogawa, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721003/ https://www.ncbi.nlm.nih.gov/pubmed/26790628 http://dx.doi.org/10.1186/s12933-016-0335-3 |
Ejemplares similares
-
Indirect measure of visceral adiposity ‘A Body Shape Index’ (ABSI) is associated with arterial stiffness in patients with type 2 diabetes
por: Bouchi, Ryotaro, et al.
Publicado: (2016) -
Clinical relevance of dual-energy X-ray absorptiometry (DXA) as a simultaneous evaluation of fatty liver disease and atherosclerosis in patients with type 2 diabetes
por: Bouchi, Ryotaro, et al.
Publicado: (2016) -
Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study
por: Fukuda, Tatsuya, et al.
Publicado: (2017) -
Ratio of visceral‐to‐subcutaneous fat area predicts cardiovascular events in patients with type 2 diabetes
por: Fukuda, Tatsuya, et al.
Publicado: (2017) -
Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study
por: Bouchi, Ryotaro, et al.
Publicado: (2017)